CD16low/negative Tumor-Infiltrating Lymphocyte: Lymphoid or Myeloid in Origin?: Fig. 1.
نویسندگان
چکیده
منابع مشابه
CD16(low/negative) tumor-infiltrating lymphocyte: lymphoid or myeloid in origin?
To the Editors: Although tumor-infiltrating lymphocytes (TIL) are predominantly composed of T lymphocytes, other immune cells also occur within the tumor and may be important in tumor control. We therefore read with interest the study of Schleypen et al. (1) who identified a proportion of TIL in renal cell carcinomas as natural killer (NK) cells. In some tumors, the proportion of such NK-TIL ex...
متن کاملEffects of tyrosine kinase inhibitors alone or in combination with vaccine on tumor-infiltrating myeloid cells
Purpose Tyrosine kinase inhibitors (TKIs) are considered good candidates for combination with cancer immunotherapy due to their ability to decrease myeloid-derived suppressor cells (MDSCs) in peripheral blood. However, very little is known about the effects of TKIs on myeloid cells in the tumor microenvironment. In this study we evaluated the effect of combining TKIs with vaccine on the frequen...
متن کاملTumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer
The clinical relevance of tumor-infiltrating lymphocytes (TIL) in breast cancer (BC) has been clearly established by their demonstrated correlation with long-term positive outcomes. Nevertheless, the relationship between protective immunity, observed in some patients, and critical features of the infiltrate remains unresolved. This study examined TIL density, composition and organization togeth...
متن کاملPreclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
Background Immunotherapy has become an effective cancer therapy, particularly in the case of checkpoint blockade and adoptive T cell therapy (ACT). ACT exploits the presence of tumor-infiltrating lymphocytes (TIL) by exponentially expanding their numbers ex vivo and re-infusing them into the patient in an autologous setting. With the effectiveness of TIL therapy already well established in mult...
متن کاملT Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1
T lymphocytes activated by dendritic cells (DC) which present tumor antigens play a key role in the antitumor immune response. However, in patients suffering from active cancer, DC are not efficient at initiating and supporting immune responses as they participate to T lymphocyte inhibition. DC in the tumor environment are functionally defective and exhibit a characteristic of immature phenotyp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2007
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-06-2247